Perspectives in Presbyopia: Bridging Science and Practice with Multifocal Contact Lenses
Date: 10/02/2026 ()
Venue: Online, AUSTRALIA
Provider: Joe Tanner (Coopervision)
Contact: Julia Kwok, [E] jkwok@au.coopervision.com, [P] 0438781492
Registration link: https://cvent.me/EaZe08
Activity Outline
CooperVision warmly invites you to attend a webinar to hear new perspectives on presbyopia and multifocal contact lenses. Emeritus Professor Eric Papas, co-author of the benchmark British Contact Lens Association CLEAR Presybopia report will share its evidence-based insights, while Philip Crossfield, optometrist and practice owner, will discuss his experience and key lessons from using multifocal contact lenses to differentiate his business. CooperVision Professional Affairs Manager, Julia Kwok will review the unique technologies and philosophies employed in MyDay® and Biofinity® multifocal lenses and facilitate a panel discussion to span the bridge between science and practice.
Learning Objectives
- Understand the key scientific findings and clinical insights from the BCLA CLEAR Presbyopia publications
- Understand the design and fitting approach for MyDay multifocal and Biofinity multifocal
- Identify the key messages to convey to presbyopes trialing multifocal contact lenses for optimal success
- Understand in-practice strategies to effectively grow the prescribing of multifocal contact lenses
- Discover how to integrate scientific evidence with practical strategies to enhance patient outcomes
Max CPD hours awarded: 1.5
Session Information
| Name |
|---|
| Evidence-based Insights into Presbyopia |
| Clinical? |
| Yes |
| Interactive? |
| No |
| Therapeutic? |
| No |
| Duration of CPD Session/Module |
| 0.5 |
| Duration of CPD Session/Module inclusive of Assessment Component |
| 0.5 |
| Name |
|---|
| Evolution from Biofinity multifocal to MyDay multifocal |
| Clinical? |
| Yes |
| Interactive? |
| No |
| Therapeutic? |
| No |
| Duration of CPD Session/Module |
| 0.25 |
| Duration of CPD Session/Module inclusive of Assessment Component |
| 0.25 |
| Name |
|---|
| Interview and Panel Discussion |
| Clinical? |
| Yes |
| Interactive? |
| No |
| Therapeutic? |
| No |
| Duration of CPD Session/Module |
| 0.75 |
| Duration of CPD Session/Module inclusive of Assessment Component |
| 0.75 |